HER2-Positive Inflammatory Breast Cancer Challenges of Clinical Practices.

Cureus · 2022 · PMC8986522 · PMID 35399412

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In a retrospective analysis of patients with IBC being treated in MD Anderson, the efficacy of anti-HER2 therapy in terms of prolonging OS and DFS did not reach statistical significance, despite improving pCR [ 6 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.